Chondrosulf


Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 20.5%
Osteoarthritis 17.8%
Rheumatoid Arthritis 13.7%
Fibromyalgia 6.8%
Hypertension 5.5%
Rhinitis 5.5%
Osteoporosis 4.1%
Abdominal Pain Upper 2.7%
Ill-defined Disorder 2.7%
Infection 2.7%
Ischaemic Cardiomyopathy 2.7%
Product Used For Unknown Indication 2.7%
Type 2 Diabetes Mellitus 2.7%
Arthritis 1.4%
Atrial Fibrillation 1.4%
Basedow's Disease 1.4%
Dyslipidaemia 1.4%
Herpes Zoster 1.4%
Hypothyroidism 1.4%
Neck Pain 1.4%
Agranulocytosis 12.9%
Transaminases Increased 9.7%
Anaemia 6.5%
Bronchopneumopathy 6.5%
Cytolytic Hepatitis 6.5%
Fall 6.5%
Skin Exfoliation 6.5%
Troponin Increased 6.5%
Blood Glucose Increased 3.2%
Bone Marrow Failure 3.2%
Dermatitis Bullous 3.2%
Dermatitis Exfoliative 3.2%
Drug Reaction With Eosinophilia And Systemic Symptoms 3.2%
Liver Injury 3.2%
Polyarthritis 3.2%
Purpura 3.2%
Tachycardia 3.2%
Thrombocytopenia 3.2%
Tonsillitis 3.2%
Toxic Skin Eruption 3.2%
Concomitant
Product Used For Unknown Indication 28.1%
Osteoarthritis 10.2%
Drug Use For Unknown Indication 10.0%
Osteoporosis 6.5%
Hepatitis C 5.8%
Hypertension 5.3%
Atrial Fibrillation 4.2%
Depression 3.5%
Atypical Mycobacterial Infection 3.0%
Breast Cancer 2.8%
Anaesthesia 2.3%
Bronchitis 2.3%
Hypercholesterolaemia 2.3%
Type 2 Diabetes Mellitus 2.3%
Pain 2.1%
Hiv Infection 1.9%
Lung Disorder 1.9%
Musculoskeletal Pain 1.9%
Neuralgia 1.9%
Polyarthritis 1.9%
Thrombocytopenia 8.0%
Toxic Skin Eruption 8.0%
Vomiting 8.0%
Anaemia 6.8%
Renal Failure Acute 6.8%
Withdrawal Syndrome 6.8%
Hyponatraemia 5.7%
Acute Myeloid Leukaemia 4.5%
Lung Disorder 4.5%
Rash Maculo-papular 4.5%
Vision Blurred 4.5%
Visual Acuity Reduced 4.5%
Death 3.4%
Fall 3.4%
Headache 3.4%
Hypertension 3.4%
Hypoglycaemia 3.4%
Malaise 3.4%
Muscle Haemorrhage 3.4%
Scleroderma 3.4%

Drug Data